HROW Q3 2021 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q3 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$19M+29.9% YoY

Gross Profit

$14M73.6% margin

Operating Income

-$4M-19.9% margin

Net Income

-$8M-44.5% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+3.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$103M

Total Liabilities

$87M

Stockholders' Equity

$17M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$14M	+29.9%
Gross Profit	$14M	$11M	+28.6%
Operating Income	-$4M	$2M	-332.7%
Net Income	-$8M	$9M	-196.4%

Revenue Segments

Product sales net

$18M95%

Commissions

$900,0005%